- 1. Teslac
- (UMLS (NCI) C0740162) =Steroid; Pharmacologic Substance; Hormone
| - 19. Testicular Mixed Germ Cell-Sex Cord Neoplasm
- (UMLS (NCI) C1336719) Testicular Mixed Germ Cell-Sex Cord Tumor;
Testicular Mixed Germ Cell-Sex Cord-Stromal Neoplasm;
Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor;
Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified =Neoplastic Process ;
|
- 2. Tespamin
- (UMLS (NCI) C0729087) Tespamine;
=Organophosphorus Compound; Pharmacologic Substance; Hazardous or Poisonous Substance | - 20. Testicular Non-Neoplastic Disease
- (UMLS (NCI) C1336723) Testicular Non-Neoplastic Disorder;
=Disease or Syndrome ;
|
- 3. Test
- [A procedure for critical evaluation; a means of determining the presence, quality, or truth of something. ( NCI )] (UMLS (NCI) C0039593) =Functional Concept
| - 21. testicular self examination
- [ ] (UMLS (CSP) C0436138) =Health Care Activity
|
- 4. Test Result
- [The outcome of a laboratory test. ( NCI )] (UMLS (NCI) C0456984) =Finding
| - 22. Testicular Teratoma with Non-Germ Cell Malignancy
- [This is a new term included in the 2003 edition of the WHO classification of testicular tumors. Previously, testicular teratomas were classified as mature, immature, and "with malignant transformation". WHO '03 reorganizes the classification into two categories: teratoma and teratoma with somatic-type malignancy (possibly "non-germ cell malignancy"). It is clear by now that teratomas (both mature and immature) in postpubertal patients can be associated with metastases. In contrast, teratomas (both mature and immature) in prepubertal patients are always benign (from the 2003 International Society of Urological Pathology companion meeting syllabus-annual meeting of the United States and Canadian Academy of Pathology).--2002 ( NCI )] (UMLS (NCI) C1336729) Testicular Teratoma with Somatic-Type Malignancy =Neoplastic Process ;
|
- 5. Test strip
- [Chemical, Test strip ( HL7V3.0 )] (UMLS (HL7) C1553116) =Laboratory Procedure =ObservationMethod;
| - 23. Testis Specific Protein, Y-Linked
- [Likely up-regulated by androgen and expressed in spermatogonia and spermatocytes by human TSPY Gene, 308-aa 35-kDa phosphorylated cytoplasmic Testis-Specific Y-Encoded Protein may be involved in sperm differentiation and proliferation. (NCI) ( NCI )] (UMLS (NCI) C1336731) Testis-Specific Y-Encoded Protein;
TSPY;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 6. test tube baby
- [ ] (UMLS (CSP) C0033271) =Vertebrate
| - 24. Testis Specific Protein, Y-Linked 1 Gene
- [This gene is putatively involved in sperm differentiation and proliferation. ( NCI )] (UMLS (NCI) C1421207) TSPY1;
TSPY1 Gene =Gene or Genome |
- 7. Testate
- (UMLS (NCI) C0733492) =Steroid; Pharmacologic Substance; Hormone
| - 25. Testis Specific Serine/Threonine Kinase Substrate
- [Greater than 24-kb, 11-exon human TSKS Gene encodes 592-aa 65-kDa Testis-Specific Kinase Substrate, expressed highest in the testis. With 73% amino acid identity to mouse Tsks, TSKS has an N-terminal signal peptide, several potential phosphorylation and glycosylation sites, but no transmembrane region. TSKS may play a role in testicular physiology, spermatogenesis or spermiogenesis. (NCI) ( NCI )] (UMLS (NCI) C0968477) Testis-Specific Kinase Substrate;
TSKS;
TSKS1;
=Amino Acid, Peptide, or Protein; Enzyme ;
|
- 8. Testicular Carcinoma
- (UMLS (NCI) C0677483) =Neoplastic Process ;
| - 26. Testis-Specific Kinase Substrate Gene
- [This gene may be involved in spermatogenesis or spermiogenesis. ( NCI )] (UMLS (NCI) C1336680) TSKS;
TSKS Gene =Gene or Genome ;
|
- 9. Testicular Dermoid Cyst
- (UMLS (NCI) C1336706) =Neoplastic Process ;
| - 27. Testolin
- (UMLS (NCI) C0723656) =Steroid; Pharmacologic Substance; Hormone
|
- 10. Testicular Disease
- [deviation from or interruption of the normal structure or function of the testis. ( CSP )] (UMLS (NCI) C0039584) =Disease or Syndrome =DISEASES OF MALE GENITAL ORGANS;
gonad disorder;
Male Reproductive System Disease;
=Cryptorch/niet ingedaalde testis;
orchitis;
Neoplasm of Testis;
testicular feminization;
Cryptorch/niet ingedaalde testis;
orchitis;
Neoplasm of Testis | - 28. Testosterone 17Beta-Undecylate
- [An orally active eleven-carbon ester form of Testosterone. The number of ester carbon atoms correlate with the half-life of the prodrug. Testosterone inhibits gonadotropin secretion from the pituitary gland and ablates estrogen production in the ovaries, thereby decreasing endogenous estrogen levels. In addition, this agent promotes the maintenance of male sex characteristics and is indicated for testosterone replacement in hypogonadal males. (NCI04) ( NCI )] (UMLS (NCI) C0076195) =Steroid; Pharmacologic Substance ;
|
- 11. TESTICULAR DYSFUNCT NOS
- [ ] (UMLS (ICD9CM) C0405581) =Disease or Syndrome
| - 29. testosterone binding protein
- [ ] (UMLS (CSP) C0597843) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 12. testicular feminization
- [aspects of female morphology in a XY genotype caused by defects in cellular receptors for testosterone and dihydrotestosterone, transmitted as an x-linked trait. ( CSP )] (UMLS (CSP) C0936016) Testicular Feminization Syndrome =Disease or Syndrome =Feminization;
Genetic Condition;
sex differentiation disorder;
Testicular Disease;
congenital reproductive system disorder;
sex development disorder | - 30. testosterone biosynthesis
- [ ] (UMLS (CSP) C0599476) =Molecular Function
|
- 13. Testicular Germ Cell Tumor Non-Seminomatous
- (UMLS (NCI) C1336724) Testicular Non-Seminomatous Germ Cell Tumor;
=Neoplastic Process ;
| - 31. Testosterone enanthate
- [A long-acting intramuscular form of the androgen testosterone. Testosterone inhibits gonadotropin secretion from the pituitary gland and ablates estrogen production in the ovaries, thereby decreasing endogenous estrogen levels. In addition, this agent promotes the maintenance of male sex characteristics and is indicated for testosterone replacement in hypogonadal males, delayed puberty, and metastatic mammary cancer. (NCI04) ( NCI )] (UMLS (NCI) C0076189) =Steroid; Pharmacologic Substance; Hormone =(17Beta)-17-hydroxyandrost-4-en-3-one;
=TESTOSTERONE ENANTHATE 200 MG/ML;
TESTOSTERONE ENANTHATE 100 MG/ML;
TESTOSTERONE ENANTHATE 180 MG/ML;
TESTOSTERONE ENANTHATE 100 MG;
TESTOSTERONE ENANTHATE 200 MG;
TESTOSTERONE ENANTHATE 90 MG/ML;
|
- 14. TESTICULAR HYPERFUNCTION
- [ ] (UMLS (ICD9CM) C0154215) =Disease or Syndrome
| - 32. Testosterone Isobutyrate
- [An four-carbon ester form of Testosterone. The number of ester carbon atoms correlate with the half-life of the prodrug. Testosterone inhibits gonadotropin secretion from the pituitary gland and ablates estrogen production in the ovaries, thereby decreasing endogenous estrogen levels. In addition, this agent promotes the maintenance of male sex characteristics and is indicated for testosterone replacement in hypogonadal males. (NCI04) ( NCI )] (UMLS (NCI) C0076192) =Steroid; Pharmacologic Substance; Hormone
|
- 15. Testicular Infarction
- (UMLS (NCI) C0392041) =Disease or Syndrome ;
| - 33. testosterone receptor
- [ ] (UMLS (CSP) C0076194) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 16. Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension
- (UMLS (NCI) C1336710) =Neoplastic Process ;
| - 34. Testostroval
- (UMLS (NCI) C0701000) =Steroid; Pharmacologic Substance; Hormone
|
- 17. Testicular Leukemia
- [A myeloid or more commonly lymphoid leukemia (acute or chronic) affecting the testis. Microscopically, there is interstitial infiltration of the testis by leukemic cells. Acute lymphoblastic leukemia with testicular involvement is not uncommon in boys. Sometimes (up to 10% of the cases), testicular involvement may be the initial manifestation of relapsed acute lymphoblastic leukemia. —03 ( NCI )] (UMLS (NCI) C1336711) =Neoplastic Process ;
| - 35. Testred
- (UMLS (NCI) C0917827) =Steroid; Pharmacologic Substance; Hormone
|
- 18. Testicular Mass
- (UMLS (NCI) C0241353) =Sign or Symptom
| |
home
